Lupin Pharmaceuticals Inc. recalls Ganirelix Acetate Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
- Products
-
- Ganirelix Acetate Injection
- Company
- Lupin Pharmaceuticals Inc.
- Where it was sold
-
FL, MA, MI & OH
States: Florida, Massachusetts, Michigan, Ohio
- Units affected
- 32736 vials
- About this recall
- Ganirelix Acetate Injection, 250 mcg/0.5mL, Single-dose Sterile Prefilled Syringe, 27 gauge by 1/2' needle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-274-01